Boehringer Ingelheim Reveals Hidden Global Impact of Veterinary Care
Ingelheim, Germany, May 25, 2026 Boehringer Ingelheim has unveiled new findings from a large international veterinary survey revealing the...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Ingelheim, Germany, May 25, 2026 Boehringer Ingelheim has unveiled new findings from a large international veterinary survey revealing the...
Indianapolis, Indiana, USA – May 18, 2026 Elanco Animal Health Incorporated announced the phased U.S. launch of Befrena™ (tirnovetmab),...
